Authors


Sandra Grosworsel Schefler

Latest:

Trials in Latin America

An overview of the clinical research landscape in this emerging region that also looks at its challenges.


Oracle Health Sciences

Latest:

Outsourcing to CROs: Expediting Clinical Operations or Oversight Nightmare?

Simply handing off multi-million-dollar studies to CROs without carefully crafted plans for communications and reporting operational data as the study unfolds is hardly a wise move, yet what kind of oversight is needed? Live: Tuesday, Apr. 28, 2020 1pm EDT | 12pm CDT | 10am PDT On demand available after airing until Apr. 28, 2021. Register free


Karla Beckner White

Latest:

Planning an EDC Clinical Trial

Readers share their experiences


John F. Kouten

Latest:

A Ten Step Trial Crisis Plan

Today's drug sponsors need to prepare and practice for worst-case clinical trial scenarios.


Mayelin Troche Concepción

Latest:

Documenting Adverse Events

Analysis of hematology and blood chemistry's AEs in sponsor's databases.


Stefan Paepke

Latest:

EHR and EDC Integration in Reality

An evaluation of the Munich Pilot and the affects of the EHR-EDC integration solution.


Anthony Costello

Latest:

Interactive Informed Consent: Better Informed Patients, Better Trials

In July, at a meeting called by the U.S. Department of Health and Human Services on Human Research Protections, I reviewed the fascinating results of a randomized study that recently compared paper-based informed consent to electronic informed consent.


Imogene Grimes

Latest:

An Assessment of Adaptive

Understanding and using adaptive trial design to achieve the most of its available advantages.



Karen Politis Virk

Latest:

Language & Culture in Global Clinical Trials

With more clinical trials conducted overseas, sponsors are facing new obstacles.



Nicole Harzendorf

Latest:

EHR and EDC Integration in Reality

An evaluation of the Munich Pilot and the affects of the EHR-EDC integration solution.


Shilpa Viswanathan

Latest:

Late Phase Patient Reported Outcomes

Patient-level feedback from later studies provides a multitude of valuable answers to all stakeholders.


Jürgen Schäfer

Latest:

European Pediatric Informed Consent and AF: Current Status of Country Requirements

The Pediatric Working Group of EUCROF launched an initiative to achieve standardization of generic Informed Consent Form and Assent Form templates within European countries. The differences are noted based on a prior survey.


Michael Weis

Latest:

The Quality Coach

The right person can successfully promote proper management of quality and compliance, leading to desired clinical trial outcomes.


Murtuza Bharmal

Latest:

Direct-to-Patient Enrollment Strategies

A comparison of the yields and costs of online outreach methods to other recruitment techniques.


Pietro Bonacossa

Latest:

New Ways to Recruit Trial Subjects

To minimize time to market, sponsors must explore new subject recruitment techniques.



David Levin

Latest:

Medical Device Trials

Understanding the United States' regulatory pathways and clinical operations.


Jim Kremidas

Latest:

Perspective and Hope From the ‘Other Side’

Jim Kremidas, former executive director, Association of Clinical Research Professionals, shares his experiences as a patient in clinical trials.


James R Langabeer II

Latest:

Financial Simulation Modeling

With a PC and some software you can generate realistic projections that save time and money.


Aymara Lorente, MD

Latest:

Documenting Adverse Events

Analysis of hematology and blood chemistry's AEs in sponsor's databases.


Michael E. Marcarelli

Latest:

Medical Device Compliance

A probability sampling assessment by FDA takes a look at compliance in the medical device world.


Jessica Dolfi

Latest:

Mastering Currency Fluctuation

Step-by-step process for budgeting global trials that uses a Currency Risk Management method.


Christopher Dell

Latest:

Planning an EDC Clinical Trial

Readers share their experiences


Mike Page

Latest:

Early Labeling Pays

Even before trials start, compiling a "target label" can add value by helping steer product development.


Ulrike Shwarz-Boeger

Latest:

EHR and EDC Integration in Reality

An evaluation of the Munich Pilot and the affects of the EHR-EDC integration solution.


David Handelsman

Latest:

A Canary in a Coal Mine?

How the ability to apply text mining and signal detection algorithms to social media's real-time data provides unheard of value.


Danielle Egnozzi

Latest:

Growth for Welsh Companies

A rising initiative in Wales led by the International Business of Wales (IBW) promotes company growth in the region.


Liana Martinez Pérez

Latest:

Documenting Adverse Events

Analysis of hematology and blood chemistry's AEs in sponsor's databases.

© 2024 MJH Life Sciences

All rights reserved.